Translate this page into:
Building Real-World Evidence Infrastructure to Improve Health and Healthcare in the United States: Part II—How Coordinated Registry Networks Operate Like Systemic Coordinated Inter-Organizational Networks

*Corresponding author: Osman Nuri Yogurtcu, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA osman.yogurtcu@fda.hhs.gov
-
Received: ,
Accepted: ,
How to cite this article: Yogurtcu ON, Gressler LE, Eldrup-Jorgensen J, Haqqi K, Shepard C, Panagiotou OA, et al. Building real-world evidence infrastructure to improve health and healthcare in the United States: Part II—How coordinated registry networks operate like systemic coordinated inter-organizational networks. Int J Transl Med Res Public Health. 2025;9:S26–36. doi: 10.25259/IJTMRPH_75_2024
Abstract
Background and Objective:
Coordinated Registry Networks (CRNs) are networks of healthcare partners that create and utilize information from clinical society registries and other sources to drive evidence-based improvements in healthcare. In Part I of this three-part series, we introduced the systemic coordinated inter-organizational networks (SCIONs) theory, which is proposed as a unique mode of societal coordination that fosters trust, cooperation, and adaptability among partner organizations to address complex societal problems, including healthcare. In this article, we analyze how CRNs function like SCIONs to better understand how CRNs can promote innovation to improve outcomes, quality, and efficiency.
Methods:
The SCIONs theory is used to describe the structure and functions of CRNs and to consider how they might be optimized in practice. We apply the SCIONs theory to an extended case study of the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) to describe the structure and functions of this CRN.
Results:
The criteria to identify SCIONs—characteristics, modes of coordination, and performance evaluation— are applied to the VQI as CRN (and to the VQI as an extended case study). CRNs may drive radical innovation in quality improvement, research, regulatory decision-making, and medical product development. The consequences of these innovations in vascular surgery have been measured by reduced patient stays, reduced barriers in care access, and improved care quality metrics. A partnership between the SVS VQI and the Medical Device Epidemiology Network further expanded VQI’s capabilities and integrated Medicare data for a robust evaluation of patient outcomes. Key factors making innovation possible include regional sub-networks, collaborative stakeholder relationships, and a dedicated network-coordinating organization that provides technical expertise, leadership, and data quality assurance for effective collaboration.
Conclusion and Implications for Translation:
The description of the VQI as a SCION offers a generalizable model for the CRN as real-world data collection and analysis that has transformed healthcare delivery and improved patient outcomes at scale. The CRN model is proposed for development broadly across medical and surgical specialties in the US as well as primary care.
Keywords
Evidence-Based Medicine
Learning Social Theory
Public Health
Public Reporting of Healthcare Data
Quality Improvement
Registries
INTRODUCTION
In this Part II of a three-part series, organizational models for building infrastructure for real-world evidence (RWE) are applied to particular clinical examples to better understand how CRNs function. Part I described the Coordinated Registry Network (CRN) as a strategic partnership concept that connects clinical registries with other real-world data (RWD) sources—such as medical claims databases, national mortality data, patient-reported outcomes, and sensors—to generate evidence that addresses a wide range of healthcare needs. Part I also introduced a sociological theory known as the systemic coordinated inter-organizational networks (SCIONs), a non-governmental structure capable of solving societal problems that are not successfully addressed by government or market forces.[1]
METHODS
This article explains how the defining criteria of SCIONs operate in CRNs to improve patient outcomes and achieve a variety of public health goals through their unique functions. First, we apply the defining characteristics for SCIONs—coordination mechanisms and performance evaluation—to CRNs, drawing from the broad range of experience across different clinical specialties. Then, we apply the SCIONs theory to the CRN known as the Society for Vascular Surgery Vascular Quality Initiative and the Vascular Implant Surveillance and Interventional Outcomes Network (VQI/VISION). While this work focuses on the structure and function of CRN as a unique type of organization, examples of how they have improved health and accelerated innovation are also provided; organizational change in SCIONs—learning, innovation, and adaptation—are illustrated by CRN accomplishments. Lastly, we discuss the translational implications for program managers, government agencies, and the public.
RESULTS
SCIONs Criteria Applied to CRN: Characteristics, Coordination Mechanisms, and Performance Evaluation
The criteria to identify SCIONs include characteristics, modes of coordination, and performance evaluation. We illustrate these criteria with examples from existing CRNs. This section examines the structure and function of a diverse CRN community of practice, while also documenting how CRNs have improved health outcomes, quality, safety, and reduced unnecessary care. Following sections provide specific examples of performance evaluation in this context.
Characteristics
SCIONs are defined by the following characteristics: (1) a network of organizations, (2) pursuing or contributing to a common desired goal, and (3) with an autonomous unit coordinating their related activities, with (4) technical staff and methods of measuring and evaluating performance [Table 1]. CRNs demonstrate these characteristics in the following ways:
| Characteristics of CRNs | |
|---|---|
| Organizations | Through voluntary participation of clinical units and other stakeholders, CRNs provide QI in specified clinical areas to benefit all units. Other shared goals (using data created by CRNs for research and innovation) have developed in more mature CRNs. |
| Systemic | The number of clinical partners in the network varies between 30 and over 900 for active CRNs. Industry and government agencies participate as partners and users of data. |
| Coordination | All CRNs have NCOs organized as 501(c)(3) or PSO. |
| Technical staff | NCO staff collaborate with clinical units, providing support and supervision to facilitate data collection. |
| CRN coordination mechanisms | |
| Allocating | The NCO and associated governing bodies work to gather funds from members and coordinate sharing of resources. Funds generated from registry activities are used for group efforts and individual members. |
| Controlling | NCOs of CRN provide supportive supervision of registry activities. Clinical activities are influenced through interactions comparing clinical performance of member units with peers and through training. NCO also controls data activities to ensure data aggregated across various member units can be meaningfully aggregated and compared. |
| Stimulating cooperation | QI of patient care is a common goal established by the CRN. Sharing information between members is accomplished through the many committees and meetings of the CRN. The flow of funds varies depending on the specific business model of the CRN, as the NCO works to decrease the burden of participation in the network to ensure that benefits outweigh the burdens. Many CRNs have regional entities that work together under the general umbrella of national CRNs. |
| CRN performance evaluation criteria | |
| Learning | CRNs have a well-documented record of participating clinical centers learning through improved implementation of clinical standards and working with registries to collect data in a prescribed manner. |
| Innovation | Clinical centers in CRNs develop and test improvements in clinical process; those innovations are evaluated and spread across the network as best practices. CRNs have also been used to develop novel treatments and products. Data from the CRNs have been used to to evaluate medical products. |
| Adaptation | CRNs have successfully supported CMS changes in requirements for reimbursement for clinical services through PQRS, registry activity to support “pay for performance” initiatives, and CRN data have been used to support HHS national goal setting. |
| Effectiveness | Comparison of measures of quality is core to the QI goal of CRN. Measurement is critical to efforts to appropriately standardize practice across various practices, to identify best practices and efficiencies, and to improve outcomes/decrease heterogeneity of effect. |
CRN: Coordinated registry network, SCION: Systemic coordinated inter-organizational network, NCO: Network coordinating organization, QI: Quality improvement, PQRS: Physician quality reporting system, CMS: Centers for medicare and medicaid services, HHS: Department of health and human services.
Systemic. CRNs are voluntary networks of between 30 and 1,000 clinical facilities that may be hospitals, freestanding clinics, or group or solo practices that, as a network, come together around shared goals for improving patient outcomes and efficiency of care in a specific clinical specialty. They address institutional and systemic problems. Mature CRNs support additional goals of stakeholders, including public health preparedness, clinical trial conduct, medical product development, and regulatory decision-making.[2,3,4] Mature CRNs typically partner with industry (e.g., for medical products and information technology) and government agencies to coordinate data standards and data needs as partners.[5,6] Mature CRNs also have formal interfaces with patient organizations and patient advisors.[7,8] These organizations unite as part of the US healthcare system to produce health and healthcare for the US population.
Organizational. CRNs are typically run by a network-coordinating organization (NCO) that operates as a 501(c) (3) organization to promote public health or science or as a 501(c)(6) organization that promotes common business interests. These organizational relations are distinct from the personal relationships between individuals that may develop as a result of their work. The NCO is an autonomous organization with its own CEO and board, which is likely composed of representatives from its members.
Coordination. Each operating CRN has an independent CEO affiliated with one or more clinical societies that coordinate activities around shared goals.[9] Coordination includes management of various data types involving extraction,[10–12] curation,[13] standardization,[14] interoperability,[15–16] and harmonization[14] processes to ensure seamless integration into a multipurpose, accessible data source. The NCOs of CRNs have brought together legacy activities (e.g., quality improvement [QI] efforts and registries) and combined them into robust organizations.[17–18]
Technical staff. NCOs’ full-time technical staff collaborates with network members in a supportive and supervisory manner on clinical and data management activities. The NCO staff facilitates committees that support ongoing clinical efforts such as improving guidelines, developing training programs, and coordinating peer-to-peer support for QI. NCO staff lead multiple committees and information technology contractors that sustain data management. The clinical and other unique skills of the staff and committees make this work possible.
Physician-scientists[19] are critical participants in technical coordination activities. The role of the physician-scientist in a CRN can be described as a “boundary spanner,” a term for an individual who crosses the group boundaries to enable knowledge exchange, translate language, and share values among various groups.[20] Their scientific training and clinical skills uniquely position them to bring together clinical and investigational efforts.[21]
Coordination Mechanisms
CRNs use three coordination mechanisms described for SCIONs: allocating, controlling, and stimulating cooperation.
Allocating. The NCO allocates resources across the network partners and pays support contracts. Depending on the CRN’s financial model, resources may be in the form of services or payments flowing from the NCO to the CRN network clinical partners or in reverse. Each stakeholder can contribute to and benefit from the CRN in unique ways.[22] In some CRNs, funds flow from the NCO to members for services. Overall, NCOs allocate a mixture of funds, services, and shared tools to support the data activities and processes that help clinical entities change their processes to improve quality.
Controlling. The NCO exercises control over data management procedures to maintain the registries. Control of the data processes of the CRN is critical to ensuring the quality and utility of the data. Data quality reporting requirements are conditions of membership. According to the SCION literature, the NCO has the authority to remove organizations from the network due to poor performance.[1] Although this is formally true for CRNs, the authors are unaware of any instances where a clinical unit’s inability to contribute data of sufficient quality led to its removal from the network. Voluntary exit from the CRN is known but rare.
Stimulating Cooperation. CRNs use allocation and control as mechanisms of coordination, but what distinguishes their work is the cooperation between clinical entities. The NCO stimulates cooperation by encouraging the sharing of information between members about clinical and data-related activities in ways that are more effective and faster than other communication mechanisms (e.g., peer-reviewed publications). The network stimulates cooperation by coordinating joint scholarly activities, facilitating peer-to-peer consultation, sharing best practices, and promoting shared issues. Cooperation is facilitated by many committees of volunteers from different clinical entities and partners who represent human capital across the network.[3,23]
Performance Evaluation
Performance evaluation as a core function of CRNs represents another way in which CRNs operate like SCIONs. The CRN’s foundational purpose is to measure the quality of clinical care. As they mature, CRNs function to expand these activities to produce three types of organizational change evaluated in the SCIONs literature: learning, innovation, and adaptation.[3]
Learning. Organizations learn through CRNs by diffusing knowledge through the network. In clinical medicine broadly, the slow pace of diffusion of new knowledge and implementation into practice (from bench to bedside) is well documented.[24] CRNs more effectively promote the implementation of innovations in many clinical areas (interventional cardiology,[25] medical cardiology,[26] vascular surgery,[27] hernia repair,[28] oncology,[29] orthopedics,[30] and breast surgery[31]). In certain clinical areas, CRNs have measured the rate of new knowledge diffusion and the adoption of clinical guidelines.[26]
Organizational learning in CRNs is observed through the implementation of care standards across their networks. Training, monitoring,[32] and sharing of experiences and data across the network further enhance social integration in different clinical settings. As described in Part I, CRN learning that improves the quality of care represents a paradigm shift, a radical change, when contrasted to traditional top-down process management models, which have often shown limited impact.[33–35]
Innovation. CRNs have made new knowledge, procedures, clinical guidelines, and the development of medical products possible. The unique collaborative relationships between the CRN clinical members who share experience and data speed innovation. For example, CRNs have used data to produce new knowledge about racial, sexual, and socioeconomic differences in healthcare.[36–46] Registry data suggests that minority racial groups are underrepresented among patients undergoing transcatheter aortic valve replacement (TAVR) in the US. However, once engaged in care, their adjusted 30-day and 1-year clinical outcomes are comparable with those of white patients.[40]
New procedures and guidelines have been developed in CRNs, as well as new indications for existing products through Food and Drug Administration label modifications supported by CRN data.[47] Procedural innovations that improve safety and treatment outcomes are especially well addressed by large information-sharing networks.[48] For instance, the use of the National Cardiovascular Disease Registry linked to CMS claims data supported expanding the indication for transcatheter valve therapy (TVT) to include older patients.[40] CRN-funded epidemiological studies have led to refinements of clinical guidelines to address differences in patient and disease characteristics.[49] Evaluation of different clinical definitions of disease between clinical centers has led to refinements that support patient selection for treatment and improved outcomes.[26]
The iterative nature of medical product development may make CRNs a useful context for product innovation.[50] The National Cardiovascular Data Registry (NCDR®) supported innovations in TAVR across three generations for two companies’ products, iteratively addressing challenges identified through the TVT and other large registries.[51] The highly competitive nature of medical product development places limitations on what CRNs can contribute, a topic further discussed in Part III.
While CRNs have promoted innovation, increased maturity will enhance their potential through greater systematic gap analysis, goal setting for communities of clinicians, and more systematic collaboration with entrepreneurs that increase the value created in a given CRN.
Adaptation. A CRN demonstrates SCION-like adaptation by solving problems and coping with change, offering radical, data-driven solutions. For example, projections from an active surveillance tool collecting data on cardiac pacemakers suggested that evidence of adverse events associated with a particular product could have been detected over two years earlier if the full CRN had been used.[52] Recalls of hernia mesh and breast implants are other examples of the adaptive utility of registries.
CRN registries have also been adapted for national monitoring. The American College of Cardiology data resources support the national Healthy People initiative of the US Department of Health and Human Services[53] that addresses racial and ethnic differentials in cardiovascular disease.[54] Other CRNs may offer unique data that may be adapted to national efforts for disease monitoring, particularly in clinical areas where data is not readily available to Healthy People.
CASE STUDY OF THE SOCIETY FOR VASCULAR SURGERY (SVS) VQI AND THE VISION
The same criteria used to describe SCIONs – characteristics, coordination mechanisms, and performance evaluation – are also applied to the VQI/VISION CRN.
SCION characteristics of the VQI/VISION CRN
SCION criteria are used to describe the VQI/VISION CRN, including the identification of the following components: system, organization, coordination, and technical staff.
Systemic. The VQI/VISION is the oldest and most mature of CRNs, whose components function as a system to achieve shared goals. Established in 2011, the VQI created a distributed network of pre-existing regional QI groups. The Society for Vascular Surgery Patient Safety Organization (SVS PSO) is structured as a Patient Safety Organization (PSO) and listed by the Agency for Healthcare Research and Quality (AHRQ) as described in the Patient Safety and QI Act of 2005 (Patient Safety Act).[55] The mission of the SVS VQI is “to improve the quality, safety, effectiveness, and cost of vascular healthcare.”[56]
Organizational. As of March 2024, there were 1,035 participating institutions[57] and 18 regional QI groups in the US and Canada participating in the network.[58] With over 8,000 participating physicians from multiple disciplines, the VQI covers approximately one-third of all vascular procedures in the United States, drawing from a variety of clinical settings, including those in urban, rural, and academic environments.[57]
The SVS VQI network of regional QI groups provides the structure needed to translate data into changes in clinical practice. Its central methodology is to aggregate information from multiple procedures and analyze patient outcomes to drive QI. To date, the SVS PSO VQI has participated in the data collection of over one million patient encounters.
Coordination. The SVS PSO operates as a nonprofit according to Section 501(c)(6) of the US Internal Revenue Code. Other CRNs are 501(c)(3) nonprofits[59] with different rules about accepting money from other organizations and a somewhat broader ability to participate in political activities. Despite these differences, both types of nonprofits operate similarly when viewed as CRNs. The SVS PSO can be identified as the autonomous NCO that coordinates the network. The SVS PSO operates through the efforts of an executive director and a governing board, who oversee a series of committees and programs. An SVS PSO staff composed of physicians, nurses, analysts, and administrative personnel provides clinical expertise, statistical analyses, and oversight of QI activities conducted through the PSO. Much of the coordination is decentralized in the regional groups, which act as sub-SCIONs.
The organizational structure includes a representative governing council that provides supportive supervision through several committees and programs. The Quality Committee supervises the analyses, reporting, and quality initiatives of the SVS PSO. The Research Advisory Committee, which has a similar committee structure, is responsible for reviewing member applications for the release of aggregated, de-identified data sets under select rules to participants.
Technical staff. The PSO has a full-time technical staff of 12 people. It acts as the NCO of the VQI/VISION CRN, coordinating the network. The PSO staff also works with contractors,[60] volunteer committees, and regional bodies. They coordinate activities between partners in a collaborative manner, providing technical assistance and supportive supervision. Their role is akin to that of middle managers, who facilitate organizational processes that create more effective working environments.[61]
With the assistance of the PSO staff, a volunteer physician lead, an associate physician lead, and a lead data manager oversee the 18 regional groups. The governance policy and organizational chart can be seen in SVS PSO Governance Policies.[62] A steering committee for industry studies consists of PSO members and the manufacturer who requests data from the VQI.
SCION Coordinating Mechanisms of the VQI/VISION CRN
The VQI/VISION applies SCION coordination mechanisms: allocating, controlling, and stimulating cooperation.
Allocating. Members of the network, hospitals, and other clinical entities pay membership dues. The PSO administers these funds, along with other proceeds from grants and services to industry. The PSO also allocates other resources, equipment, appropriate skills, and technologies across the network. VISION manages resources around the linked VQI and CMS claims data.
Controlling. Control of data quality, analysis, and reporting is critical to the network’s operation. VQI’s suite of 14 procedure-or disease-specific registries contains demographic, clinical, procedural, and outcomes data performed across the US, Canada, Puerto Rico, and Singapore. Biannual regional meetings allow physicians, nurses, data managers, quality officers, and others to meet, share information and ideas, and learn from each other in a collegial and supportive environment. While an NCO has formal authority to remove organizations from the network due to poor performance, VQI/VISION PSO has never dismissed a member.
Stimulating Cooperation. The VQI/VISION CRN fosters cooperation among various members through regional meetings, data analysis, and QI projects. The network shares data and experience, and regional groups convene twice a year to collectively review results. Figure 1 provides a list of the committees through which the VQI operates. To facilitate this cooperation, the VQI provides web-based tools for the collection, aggregation, and analysis of clinical data submitted by those providing vascular care. VQI collaborates with multiple organizations, including the American College of Cardiology, the American Heart Association, the Society of Vascular Medicine, the Society of Interventional Radiology, the American Venous Forum, governmental regulatory agencies, device manufacturers, and payers.

- Structure of the VQI/VISION CRN. VQI is a collaboration of the SVS PSO, 18 regional quality improvement groups organized under the SVS PSO, and FIVOS (a healthcare performance management solutions company), its commercial technology partner. VQI functions as a collecting and analyzing data voluntarily reported by healthcare providers to help improve patient safety and healthcare quality. The SVS VQI Vascular Implant Surveillance and Interventional Outcomes Network (VISION) is an independent university-based project that links Medicare claims data to the registry. VQI: Vascular quality initiative, SVS: Society for vascular surgery, PSO: Patient safety organization.
Biannual reports to clinical centers provide information on volume, outcomes, benchmarks, and process measures (such as infection rates, number of patients on statins, number of patients who stop smoking, and number of patients on antiplatelet agents). The clinical centers may initiate requests for guidance and assistance from the PSO, which is readily provided via webinars, group conference calls, and individual consultations.
SCION Performance Evaluation of VQI/VISION
VQI/VISION has documented radical organizational change in learning, innovation, and adaptation, playing a key role in identifying and disseminating QI incentives that have transformed practice patterns, enhanced quality, and reduced healthcare costs, as evidenced in over 800 peer-reviewed publications.[63]
Learning. The registries in vascular surgery have been instrumental in promoting and monitoring adherence to clinical practice guidelines developed through SVS research and expert consensus.[64,65] VQI provides opportunities for real-time monitoring of clinical practice against societal guidelines, using the data to identify needs for either education or change in practice. These activities exemplify the human capital that SCIONs have produced. Ongoing QI efforts have led to documented improvements in patient outcomes.[66] Clinical entities have successfully used the VQI/VISION CRN to monitor alignment with new clinical guidelines.[64,65] For instance, the SVS guidelines on Peripheral Vascular Intervention for claudication were released in 2015 and included optimal medical management and procedural and post-procedure recommendations. A study of 93,654 cases of claudication treatment from 2010 to 2022 documented the uptake of guidelines and changes to clinical practice.[67] Identification of groups of patients who did not receive guideline-aligned treatment, particularly those living in low-social and economic neighborhoods, will be a subject for future work using VQI data.
Innovation. Innovation in medical products and procedures is well documented through the work of the VQI/VISION CRN.
The VQI/VISION CRN facilitated improvements in care delivery and the monitoring of new products. The VQI has documented reductions in the length of hospital stay after endovascular aneurysm repair and contrast volume usage during endovascular aneurysm repair.[66] Other innovations generated medium-term outcomes data on peripheral vascular interventions and smoking cessation strategies.[66] VQI/VISION data contributed to six label changes that expanded the use of vascular product labels through post-approval studies and provided comparative data for propensity matching with existing device data.[68–69] Over the course of the past decade, evidence-based medicine has advanced in vascular surgery through the VQI/VISION.[70] Randomized clinical trials that document effective interventions have been developed in the network, and evidence-based interventions have been spread across the nation through the professional society and its many academic efforts and professional activities. Participation in the VQI registry has grown strongly, providing benchmarking and feedback to clinicians that further improved quality and outcomes. The publication of clinical practice guidelines by the SVS, while lagging behind much of the implementation of Evidence-based Medicine (EBM) into practice, has further solidified a culture of quality in vascular surgery.[71] Further evaluation is necessary to better understand the role of the VQI in the decline in peripheral arterial disease patient deaths (over 50% from the year 2000 to 2016) that has been attributed to medical care.[72]
Adaptation. The evolution of VQI/VISION CRN began in 2015, reaching full maturity by integrating longitudinal claims data into the VQI registry, enhancing utility and efficiency. VQI recognized the importance of follow-up of vascular procedures and began with a one-year follow-up. The ensuing 5–10 years of follow-up of registry data with traditional methods are expensive and often incomplete due to patients frequently changing providers, insurance, and residence. The SVS VQI/VISION[73–75] efficiently linked the patient data in VQI with Medicare claims, creating unique datasets for developing clinical details based on the availability of long-term patient outcomes. Using VISION, VQI patient follow-up can be obtained for any Medicare patient who receives care from any provider at any location (given it is a billable event).
DISCUSSION
This manuscript works to translate the vision of national RWE infrastructure into actionable efforts that promote the role and potential of CRNs. Currently, however, a minority of medical specialties have highly functional CRNs. While all clinical societies have worked in this direction (most having at least plans for CRN), they need support to build CRNs.
CRNs are not the only components needed to build that national RWE infrastructure that can provide data-driven innovation in US healthcare. Other considerations include national death index modernization,[76] provision for all-payer claims data for the population under 65,[77] further development of a comprehensive national cancer registry,[78] and semantic interoperability of laboratory data.[79] One can easily envision a federated system comprising a national network of these RWD resources. Clinical specialty societies and their CRN/registries are increasingly turning to these issues as part of their practice. Appreciation of the role of professional societies as partners with patients and taxpayers to find solutions is essential for building a national RWE network. Action theory in the SCION literature moves us away from an exclusive focus on the structure and function of organizations. Ultimately, it is the success and potential for future contributions of the CRN that motivate this work of the application of SCION theory. While the many accomplishments of CRN have been cited across this descriptive analysis, a summary of contributions is offered along with a link to the Medical Device Epidemiology Network that provides a repository of publications about CRN.[74] The application of SCION theory to CRN practice also addresses how professional societies and their quality improvement activities (including the CRN) may be improved, a subject that will be addressed in the next part of this work.
CONCLUSION AND IMPLICATIONS FOR TRANSLATION
Successful and functional CRNs were described with common features, collaborative methods, and performance rating systems illuminated by SCIONs theory. These characteristics and processes set them apart from government- or market-driven organizations. By illustrating the practical applications of CRNs, this manuscript highlights how coordination and collaboration between clinicians in different organizations can solve multiple problems, particularly those that the government and industry have not or cannot. With its unique set of characteristics and functions, the CRN supports the evidentiary needs of many partners. If properly developed, CRNs in the US can perform critical functions that national registries in Europe and other parts of the world have been so critical in improving healthcare quality and controlling costs in those countries.[80] This uniquely American solution deploys enduring features of US healthcare with its vibrant academic medical centers, private sector providers, and regional/state differences.
Most of the 40 professional clinical specialty societies represented by the Council for Medical Specialty Societies[81] either have registries or plans to develop them. Additionally, the Society for Primary Care and the National Association of Community Health Centers are developing CRNs. Managers of these initiatives may find valuable the evolving literature about CRNs to guide the development of these organizations. Frameworks for evaluating CRNs, including the assessments of the cost and efficiency of different models, may be useful to guide future investments and development.[82–83] While the many accomplishments of CRN have been cited across this descriptive analysis, a summary of contributions is offered along with a link to the Medical Device Epidemiology Network that provides a repository of publications about CRN.[84]
Considerations for translation: Currently, there is little funding or focused support for the development of CRNs across clinical specialty areas in which the care to our patients is delivered. Considerations range from direction of investment into CRNs and the development of national RWE infrastructure building, to exploration of more effective partnerships with professional societies to accelerate the adoption of EBM across the large networks provided by these societies. The acceleration of the process of production and promotion of clinical practice guidelines by the societies will also benefit from more intensive partnerships with government agencies.
Key Messages
1) Coordinated Registry Networks (CRNs) are networks of hospitals, doctors, researchers, and others who share patient data to find better treatments and improve care. The criteria and functions used to define SCIONs accurately describe the CRN. 2) The Vascular Quality Initiative (VQI) serves as a case study to illustrate how a CRN helped to improve surgical practices, provide better treatments, and track the safety of devices, e.g., stents. 3) A CRN requires an independent Network-Coordinating Organization (NCO) with dedicated and skilled staff to balance stakeholders’ needs and optimize network participants’ contributions. 4) CRNs unite different groups around a common goal through coordination mechanisms, critically including cooperation. In the VQI, each regional group works on local issues while sharing ideas and solutions with the entire organization. This contrasts with market-driven industry and the rule-driven structures of government bodies.
Acknowledgments
The authors thank Leslie H. Curtis, PhD and Danica MarinacDabic, PhD for insightful comments on this manuscript draft. Also, we thank DRT Strategies Medical Writer-Editor support for editing this manuscript. Our esteemed colleague, friend, and coauthor Kashif Haqqi, MD, passed away on March 7, 2024, at the age of 52. A visionary healthcare leader, his expertise in technology and strategic thinking revolutionized healthcare delivery and management. His dedication and knowledge helped make this manuscript possible.
COMPLIANCE WITH ETHICAL STANDARDS
Conflicts of Interest: Dr. Gregory Pappas serve as the editor of the journal. Financial Disclosure: Nothing to declare. Funding/Support: There was no funding for this study. Ethics Approval: This research does not involve human subjects and therefore raises no ethical concerns related to privacy, risk/benefit, or other standard ethical considerations. Declaration of Patient Consent: Not applicable. Use of Artificial Intelligence (AI)-Assisted Technology for Manuscript Preparation: The authors confirm that there was no use of Artificial Intelligence (AI)-Assisted Technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI. Disclaimer: The work related to strategically Coordinated Registry Networks (CRNs) that is referenced in this paper was supported in part by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of the Office of the Secretary (OS)/Assistant Secretary for Planning and Evaluation (ASPE)/Patient-Centered Outcomes Research Trust Fund (PCORTF) Program executed via Inter agency Agreement between ASPE and FDA/Center for Devices and Radiological Health (CDRH) and subsequent award U01 FD006936-01 to Weill Cornell Medicine. The contents are those of the author(s) and do not necessarily represent the official views of, and are not an endorsement by FDA/HHS, or the U.S. Government. The views, findings, and interpretations contained in this document do not constitute FDA guidance, position on this matter, or legally enforceable requirements.
Special Collection
This article is published as part of the special collection on “Building the Real-World Evidence Infrastructure to Accelerate Innovation and Improve Outcomes in Healthcare.”
References
- Saving societies from within: Innovation and equity through inter-organizational networks. In: Oxfordshire. England, UK: Routledge; 2024. p. :300.
- [CrossRef] [Google Scholar]
- Assessing efficiency (time, cost, and utility) of real-world evidence compared to legacy evidence generation: A comprehensive framework to determine value of RWE for stakeholders In: Under Review. 2024.
- [Google Scholar]
- Transcatheter valve therapy registry is a model for medical device innovation and surveillance. Health Aff (Millwood). 2015;34:328-34.
- [CrossRef] [PubMed] [Google Scholar]
- The Vascular Implant Surveillance and Interventional Outcomes (VISION) coordinated registry network: An effort to advance evidence evaluation for vascular devices. J Vasc Surg. 2020;72:2153-60.
- [CrossRef] [PubMed] [Google Scholar]
- A comprehensive framework for evaluating the value created by real-world evidence for diverse stakeholders: The case for coordinated registry networks. Ther lnnov Regul Sci. 2024;58:1042-52.
- [CrossRef] [PubMed] [Google Scholar]
- Determining value of coordinated registry networks (CRNs): A case of transcatheter valve therapies. BMJ Surgery, Interv Health Technol. 2019;1:e000003.
- [CrossRef] [PubMed] [Google Scholar]
- Advocate involvement in clinical trials: Lessons from the patient-centric I-SPY2 breast cancer trial. Med Res Arch. 2023;11
- [CrossRef] [Google Scholar]
- TMJ CRN - MDEPINET. [cited 2025 Aug 13]. Available from: https://www.mdepinet.net/tmj
- [Google Scholar]
- Building real-world evidence infrastructure to improve health and healthcare in the United States: Part I-Coordinated registry networks and systemic coordinated inter-organizational networks. Int J Transl Med Res Public Health. 2025;9:e007.
- [Google Scholar]
- Assessing adverse event reports of hysteroscopic sterilization device removal using natural language processing. Pharmacoepidemiol Drug Saf. 2022;31:442-51.
- [CrossRef] [PubMed] [Google Scholar]
- Artificial intelligence and machine learning in cardiology. Washington DC: American College of Cardiology Foundation; 2019:1312-4.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical practice improvement and redesign: How change in workflow can be supported by clinical decision support. 2009. Rockville, MD: Agency for Healthcare Research and Quality [Internet]. [cited August 23, 2024]. Available from: https://digital.ahrq.gov/key-topics/clinical-decision-support/clinical-practice-improvement-and-redesign-how-change-workflow-can-be-supported-clinical-decision
- [Google Scholar]
- Optimizing the use of electronic data sources in clinical trials: The technology landscape. Ther Innov Regul Sci. 2017;51:551-67.
- [CrossRef] [PubMed] [Google Scholar]
- Office of the Assistant Secretary for Planning and Evaluation, SHIELD - Standardization of Lab Data to Enhance Patient-Centered Outcomes Research and Value-Based Care [Internet] [cited November 26 2024]. Available from: https://aspe.hhs.gov/shield-standardization-lab-data-enhance-patient-centered-outcomes-research-value-based-care
- [Google Scholar]
- Laboratory interoperability best practices: Ten mistakes to avoid. 2013. Northfield, IL: College of American Pathologists [Internet]. [cited August 23, 2024]. Available from: https://documents.cap.org/documents/laboratory-interoperability-best-practices.pdf Northfield, IL: College of American Pathologists
- [Google Scholar]
- U.S. Food and Drug Administration. In: Public Workshop FDA/CDC/NLM Workshop on Promoting Semantic Interoperability of Laboratory Data [Internet]. 2015. [cited November 26 2024]. Available from: https://wayback.archive-it.org/7993/20170111193824/http:/www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm453897.htm
- [Google Scholar]
- A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks. Tuer lnnov Regul Sci. 2024;58:1042-52.
- [CrossRef] [PubMed] [Google Scholar]
- The Vascular Implant Surveillance and Interventional Outcomes (VISION) coordinated registry network: an effort to advance evidence evaluation for vascular devices. J Vasc Surg. 2020;72:2153-60.
- [CrossRef] [PubMed] [Google Scholar]
- Diversity and the next-generation physician-scientist. J Clin Transl Sci. 2019;3:47-9.
- [CrossRef] [PubMed] [Google Scholar]
- What roles do middle managers play in implementation of innovative practices? Health Care Manage Rev. 2017;42:14.
- [CrossRef] [PubMed] [Google Scholar]
- Addressing the physician-scientist pipeline: Strategies to integrate research into clinical training programs. J Clin Invest. 2020;130:1058-61.
- [CrossRef] [PubMed] [Google Scholar]
- The Learning Healthcare System: Workshop Summary In: Institute of Medicine (US) Roundtable on Evidence-Based Medicine. Washington (DC): National Academies Press (US); 2007.
- [Google Scholar]
- The STS-ACC transcatheter valve therapy national registry: A new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol. 2013;62:1026-34.
- [CrossRef] [PubMed] [Google Scholar]
- Road map for diffusion of innovation in health care. Health Aff (Millwood). 2018;37:198-204.
- [CrossRef] [PubMed] [Google Scholar]
- Improvement in quality indicators using NCDR® registries: First international experience. Int J Cardiol. 2018;267:13-5.
- [CrossRef] [PubMed] [Google Scholar]
- Synthesizing lessons learned from get with the guidelines: The value of disease-based registries in improving quality and outcomes. Circulation. 2013;128:2447-60.
- [CrossRef] [PubMed] [Google Scholar]
- Using the Vascular Quality Initiative to improve quality of care and patient outcomes for vascular surgery patients. Semin Vasc Surg. 2015;28:97-102.
- [CrossRef] [PubMed] [Google Scholar]
- Comparison of hernia registries: The CORE project. Hernia. 2018;22:561-75.
- [CrossRef] [PubMed] [Google Scholar]
- I-SPY 2: An adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther. 2009;86:97-100.
- [CrossRef] [PubMed] [Google Scholar]
- Patient registries in orthopedics and orthobiologic procedures: A narrative review. BMC Musculoskelet Disord. 2022;23:543.
- [CrossRef] [PubMed] [Google Scholar]
- National trends in length of stay for microvascular breast reconstruction: An evaluation of 10,465 cases using the American College of Surgeons National Surgical Quality Improvement Program Database. Plast Reconstr Surg. 2022;149:306-13.
- [CrossRef] [PubMed] [Google Scholar]
- Clinical registries and quality measurement in surgery: A systematic review. Surgery. 2015;157:381-95.
- [CrossRef] [PubMed] [Google Scholar]
- Why hospital improvement efforts fail: A view from the front line. J Healthc Manag. 2014;59:147-57.
- [CrossRef] [PubMed] [Google Scholar]
- A very public failure: Lessons for quality improvement in healthcare organisations from the Bristol Royal Infirmary. Qual Health Care. 2001;10:250-6.
- [CrossRef] [PubMed] [Google Scholar]
- Many 'Failed' Federal Healthcare Quality Programs Need to End, Analysts Say [Internet] 2020. [cited November 26 2024]. Available from: https://www.hfma.org/payment-reimbursement-and-managed-care/value-based-payment/many-failed-federal-healthcare-quality-programs-need-to-end-a/
- [Google Scholar]
- Racial disparities in invasive management for patients with acute myocardial infarction with chronic kidney disease. Circ Cardiovasc Interv. 2022;15:e011171.
- [CrossRef] [PubMed] [Google Scholar]
- Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm. 2009;6:325-31.
- [CrossRef] [PubMed] [Google Scholar]
- Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR® PINNACLE Registry. Int J Cardiol. 2021;329:209-16.
- [CrossRef] [PubMed] [Google Scholar]
- Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease an analysis of the American College of Cardiology's NCDR PINNACLE Registry. J Am Coll Cardiol. 2013;62:51-7.
- [CrossRef] [PubMed] [Google Scholar]
- Racial disparities in the utilization and outcomes of TAVR: TVT registry report. JACC Cardiovasc Interv. 2019;12:936-48.
- [CrossRef] [PubMed] [Google Scholar]
- Disparities in vascular surgery: Is it biology or environment? J Vasc Surg. 2010;51:S36-S41.
- [CrossRef] [PubMed] [Google Scholar]
- Healthcare disparities in vascular surgery: A critical review. J Vasc Surg. 2021;74:6S-14S.e1.
- [CrossRef] [PubMed] [Google Scholar]
- Gender disparities in academic vascular surgeons. J Vasc Surg. 2020;72:1445-50.
- [CrossRef] [PubMed] [Google Scholar]
- Racial disparities in vascular surgery: An analysis of race and ethnicity among US medical students, general surgery residents, vascular surgery trainees, and the vascular surgery workforce. J Vasc Surg. 2021;74:33s-46s.
- [CrossRef] [PubMed] [Google Scholar]
- An analysis of gender disparities amongst United States medical students, general surgery residents, vascular surgery trainees, and the vascular surgery workforce. J Vasc Surg. 2022;75:5-9.
- [CrossRef] [PubMed] [Google Scholar]
- Disparities in the treatment and outcomes of vascular disease in Hispanic patients. J Vasc Surg. 2007;46:971-8.
- [CrossRef] [PubMed] [Google Scholar]
- Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health Qual Life Outcomes. 2006;4:79.
- [CrossRef] [PubMed] [Google Scholar]
- NCDR: Advancing patient care, outcomes, and value through innovation and knowledge. Washington DC: American College of Cardiology Foundation; 2021:224-6.
- [CrossRef] [PubMed] [Google Scholar]
- Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/ American Heart Association guidelines recommendations. Am J Cardiol. 2007;99:189-96.
- [CrossRef] [PubMed] [Google Scholar]
- 2017 Roadmap for innovation-ACC health policy statement on healthcare transformation in the era of digital health, big data, and precision health: A report of the American College of Cardiology Task Force on Health Policy Statements and Systems of Care. J Am Coll Cardiol. 2017;70:2696-18.
- [CrossRef] [PubMed] [Google Scholar]
- STS-ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol. 2020;76:2492-516.
- [CrossRef] [PubMed] [Google Scholar]
- A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks. Ther Innov Regul Sci. 2024;58:1042-52.
- [CrossRef] [PubMed] [Google Scholar]
- The US Department of Health and Human Services, Healthy People 2030 Framework [Internet] [cited January 11 2024]. Available from: https://health.gov/healthypeople/about/healthy-people-2030-framework
- [Google Scholar]
- Eliminating disparities in cardiovascular health: Six strategic imperatives and a framework for action. Circulation. 2005;111:1332-6.
- [CrossRef] [PubMed] [Google Scholar]
- Society for Vascular Surgery Patient Safety Organization. LLC [Internet]. [cited January 11, 2024]. Available from: https://pso.ahrq.gov/pso/society-vascular-surgery-patient-safety-organization-llc
- [Google Scholar]
- SVS VQI Collaboration [Internet] [cited August 23 2024]. Available from: https://www.vqi.org/partners-collaborations/vqi-overview/
- [Google Scholar]
- Participating SVS VQI Centers [Internet] [cited August 23 2024]. Available from: https://www.vqi.org/about/participating-vqi-centers/#about
- [Google Scholar]
- Current Regional Groups [Internet] [cited August 23 2024]. Available from: https://www.vqi.org/regional-groups/#current-regional-groups
- [Google Scholar]
- 501c3 versus 501c6 Organizations Examined. 2018. [cited November 26 2024]. Available from: https://www.marcumllp.com/insights/501c3-versus-501c6-organizations-examined
- [Google Scholar]
- See List of Contractors Serving the Needs of VQI at FIVOS Health [Internet] FIVOS Health. [cited November 26, 2024]. Available from: https://fivoshealth.com/about-us/
- [Google Scholar]
- Uncovering middle managers' role in healthcare innovation implementation. Implement Sci. 2012;7:28.
- [CrossRef] [PubMed] [Google Scholar]
- SVS PSO Governance Policies [Internet] 2018. [cited August 23 2024]. Available from: https://www.vqi.org/wp-content/uploads/SVS-PSO-Governing-Policies-rev051418-1.pdf
- [Google Scholar]
- SVS VQI Data Analysis & Research [Internet] [cited August 23 2024]. Available from: https://www.vqi.org/data-analysis/
- [Google Scholar]
- Vascular Quality Initiative assessment of compliance with Society for Vascular Surgery clinical practice guidelines on the care of patients with abdominal aortic aneurysm. J Vasc Surg. 2020;72:874-85.
- [CrossRef] [PubMed] [Google Scholar]
- Vascular Quality Initiative assessment of compliance with Society for Vascular Surgery clinical practice guidelines on the management of extracranial cerebrovascular disease. J Vasc Surg. 2023;78:111-21.e2.
- [CrossRef] [PubMed] [Google Scholar]
- Utility of the Vascular Quality Initiative in improving quality of care in Canadian patients undergoing vascular surgery. Can J Surg. 2019;62:66-9.
- [CrossRef] [PubMed] [Google Scholar]
- Vascular Quality Initiative Compliance with Society for Vascular Surgery Clinical Practice Guidelines for the Treatment of Claudication with Peripheral Vascular Intervention [Internet] 2024. [cited November 26, 2024]. Available from: https://westernvascularsociety.org/wp-content/uploads/2024/02/2024-wvs-annual-meeting-schedule.pdf
- [Google Scholar]
- Use of data from the Vascular Quality Initiative registry to support regulatory decisions yielded a high return on investment. BMJ Surg Interv Health Technol. 2020;2:e000039.
- [CrossRef] [PubMed] [Google Scholar]
- 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: A follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial. JACC Cardiovasc Interv. 2011;4:24-9.
- [CrossRef] [PubMed] [Google Scholar]
- My view-VQI-past, present and future. In: The Vascular Quality Initiative [Internet]. 2020. [cited November 26 2024]. Available from: https://www.vqi.org/wpcontent/uploads/Past-Present-and-Future-Jens-Vision.pdf
- [Google Scholar]
- Clinical Practice Guidelines [Internet] [cited August 23 2024]. Available from: https://vascular.org/vascular-specialists/practice-and-quality/clinical-guidelines/clinical-guidelines-and-reporting
- [Google Scholar]
- Demographic and regional trends of peripheral artery disease-related mortality in the United States, 2000 to 2019. Vasc Med. 2023;28:205-13.
- [CrossRef] [PubMed] [Google Scholar]
- Five year survival in medicare patients undergoing interventions for peripheral arterial disease: A retrospective cohort analysis of linked registry claims data. Eur J Vasc Endovasc Surg. 2023;66:541-9.
- [CrossRef] [PubMed] [Google Scholar]
- The Medical Device Epidemiolgy Network VISION CRN [Internet] [cited November 26 2024]. Available from: https://www.mdepinet.net/vision
- [Google Scholar]
- SVS VQI VISION [Internet] [cited August 23 2024]. Available from: https://www.vqi.org/data-analysis/svs-vqi-vision/
- [Google Scholar]
- Modernizing the National Vital Statistics System [Internet] [cited November 26 2024]. CDC. Available from: https://www.cdc.gov/nchs/nvss/modernization.htm
- [Google Scholar]
- Realizing the Promise of All-Payer Claims Databases [Internet] 2023. [cited November 26 2024]. Available from: https://www.manatt.com/insights/newsletters/health-highlights/realizing-the-promise-of-all-payer-claims-database
- [Google Scholar]
- Digital health applications in oncology: An opportunity to seize. J Natl Cancer Inst. 2022;114:1338-9.
- [CrossRef] [PubMed] [Google Scholar]
- Analysis of laboratory data transmission between two healthcare institutions using a widely used point-to-point health information exchange platform: A case report. JAMIA Open. 2024;7:ooae032.
- [CrossRef] [PubMed] [Google Scholar]
- The role of medical registries, potential applications and limitations. Med Pharm Rep. 2019;92:7.
- [CrossRef] [PubMed] [Google Scholar]
- The Promise of Patient-Led Research Integration into Clinical Registries and Research [Internet] [cited November 26 2024]. Available from: https://cmss.org/patient-led-research-integration/
- [Google Scholar]
- A framework featuring steps and standards for program evaluation. Health Prom Pract. 2000;1:221-8.
- [CrossRef] [Google Scholar]
- Toolkit part 1: Implementation science methodologies and frameworks. Fogarty International Center, Center for Global Health Studies [Internet] 2023 Available from: https://www.fic.nih.gov/About/center-global-health-studies/neuroscience-implementation-toolkit/Pages/methodologies-frameworks.aspx
- [Google Scholar]
- The Medical Device Epidemiology Network (MDEpiNet) [Internet] [cited November 26 2024]. Available from: https://www.mdepinet.net/
- [Google Scholar]
